Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TYRA stock hub

Tyra Biosciences, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TYRAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

TYRA

In the news

Latest news · TYRA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-39.8

P25 -105.6P50 -46.5P75 -3.1

ROIC-27

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TYRA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

177

Groups with data

Currency

USD

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001863127
Company name	Tyra Biosciences, Inc.
Country	United States
Country code	US
Cusip	90240B106
Employees	87
Employees Change	27%
Employees Change Percent	45
Enterprise value	$1.8B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-09-15
Isin	US90240B1061
Last refreshed	2026-05-10
Market cap	$2B
Market cap category	Mid-Cap
Price	$34.32
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	TYRA
Website	https://tyra.bio

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.88%
FCF yield	-4.67%
P/B ratio	7.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-119.9M
Net Income Growth Years	0%
Profit Per Employee	$-1.4M
ROA	-25.68
Roa5y	-18.23
ROCE	-50.19
ROE	-39.83
Roe5y	-27.56
ROIC	-27.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	276.25%
Cagr3y	40.32%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$282.6M
Cash	$256M
Current Assets	$265.5M
Current Liabilities	$18.1M
Debt	$5.8M
Debt Equity	$0.02
Equity	$259.2M
Liabilities	$23.4M
Long Term Assets	$17.2M
Long Term Liabilities	$5.3M
Net Cash	$250.2M
Net Cash By Market Cap	$12.26
Net Cash Growth	-25.36%
Net Debt Equity	$-0.97
Tangible Book Value	$259.2M
Tangible Book Value Per Share	$4.83
WACC	8.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.67
Net Working Capital	$-8.2M
Quick ratio	14.25
Working Capital	$247.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.17%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	275.9%
200-day SMA	23.41
3Y total return	176.33%
50-day SMA	35.87
50-day SMA vs 200-day SMA	50over200
All Time High	40.65
All Time High Change	-15.57%
All Time High Date	2026-04-01
All Time Low	4.93
All Time Low Change	596.15%
All Time Low Date	2022-06-21
ATR	2.12
Beta	0.79
Beta1y	0.15
Beta2y	1.34
Ch YTD	30.54
High	34.57
High52	40.65
High52 Date	2026-04-01
High52ch	-15.57%
Low	32.94
Low52	8.75
Low52 Date	2025-05-28
Low52ch	292.23%
Ma50ch	-4.32%
Premarket Change Percent	1.82
Premarket Price	$33.5
Premarket Volume	9,375
Price vs 200-day SMA	46.59%
RSI	46.46
RSI Monthly	69.55
RSI Weekly	63.88
Sharpe ratio	2.39x
Sortino ratio	4.79
Total Return	-4.17%
Tr YTD	30.54
Tr1m	-9.04%
Tr1w	0.82%
Tr3m	10.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	11
Analyst Count Top	3
Analyst Price Target Top	$51.67
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.59
Operating Income	$-132.8M
Price target	$47.5
Price Target Change	$38.4
Price Target Change Top	$50.55

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	31,343,312%
Float Percent	52.69%
Shares Insiders	2.68%
Shares Institutions	62.54%
Shares Out	59,485,237
Shares Qo Q	0.27%
Shares Yo Y	4.17%
Short Float	24.6%
Short Ratio	7.36
Short Shares	12.96

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-123.3M
Average Volume	1,026,506.55x
Bv Per Share	4.83
CAPEX	$-141,000
Ch1m	-9.04
Ch1w	0.82
Ch1y	275.9
Ch3m	10.71
Ch3y	176.3
Ch6m	139.7
Change	4.32%
Change From Open	4.16
Close	32.9
Days Gap	0.15
Depreciation Amortization	546,000
Dollar Volume	30,753,911.8
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-132.8M
EBITDA	$-132.2M
EPS	$-2.01
F Score	1
FCF	$-95.3M
FCF EV Yield	-5.32x
FCF Per Share	$-1.6
Financing CF	8,100,000
Fiscal Year End	December
Founded	2,018
Investing CF	72,463,000
Ipr	114.5
Iprfo	14.78
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-02
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-02
Ma150	27.27
Ma150ch	25.84%
Ma20	35.19
Ma20ch	-2.48%
Net CF	-14,579,000
Next Earnings Date	2026-05-22
Open	32.95
Optionable	Yes
Position In Range	84.66
Ppne	6,887,000
Pre Close	32.9
Price Date	2026-05-08
Ptbv Ratio	7.88
Relative Volume	0.87x
Share Based Comp	28,006,000
Tr6m	139.67%
Us State	California
Volume	896,093

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TYRA pay a dividend?

Capital-return profile for this ticker.

Performance

TYRA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TYRA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+62.5%

Float: +52.7% of shares outstanding

Insider ownership

+2.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TYRA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.5

Neutral momentum band

Price vs 200-day MA

+46.6%

50/200-day relationship not available

Beta (5Y)

0.79

Less volatile than the market

Sharpe ratio

2.39

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TYRA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current TYRA stock rating?

Tyra Biosciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full TYRA analysis?

The full report lives at /stocks/TYRA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for TYRA?

The latest report frames TYRA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the TYRA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.